Biocept Inc expected to post a loss of 22 cents a share - Earnings Preview

Biocept

27/03/2023 21:36

* Biocept Inc  BIOC.OQ   BIOC.O  is expected to show a fall
in
quarterly revenue when it reports  results on March 29
(estimated). 
    * The San Diego California-based  company is expected to
report  a
76.0% decrease in revenue to $3.352 million from $13.98 million
a year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Biocept Inc is for
a loss
of 22 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Biocept Inc
is
$4​, above​ its last closing price of $0.29. ​​​

This summary was machine generated March 27 at 20:36 GMT.  All
figures in US dollars  unless otherwise stated